Cramer's 'Mad Money' Recap: Senomyx and Match

Click here for an archive of Cramer's "Mad Money" recaps.

---

Although Senomyx (SNMX Quote) has "massive losses and barely any revenues," Jim Cramer told viewers of his "Mad Money" TV show on Friday to look into buying this stock in a week or two.

"For most investors, speculation is a dirty word. But for me, it's the way to play the game," Cramer said.

Although Senomyx has almost no revenue whatsoever, he believes it's a great idea to buy this stock. Cramer advised people to put it into their "Mad Money" speculative portfolio. However, he reminded viewers that speculative stocks should take up no more than 20% of their portfolios.

Don't buy Senomyx -- a relatively unknown and small biotech company -- just yet, Cramer said. "Wait a week or two to buy it, and don't buy it after hours." Use small limit orders to buy it over time, he said.

Senomyx is the company for the current era, where people eat too many sweet and salty foods, but don't want to become obese or overweight, Cramer said.

This biotech company solves this problem by adding a chemical to foods and tricking people's taste buds. The amount of this chemical added is so small that Senomyx doesn't need to get FDA approval, Cramer said.

Senomyx has deals with Coca-Cola (KO Quote), Kraft Foods (KFT Quote), Cadbury Schweppes and Campbell Soup (CPB Quote).